Hansol Yeom
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hansol Yeom has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Jin Gwack
Department of Preventive Medicine, Jeonbuk National University Medical School, Jeonju, Korea
2 shared publications - Sook-Hyang Jeong
Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
2 shared publications - Deog-Yong Lee
Division of Viral Diseases, Department of Diagnosis and Analysis, Korea Disease Control and Prevention Agency, Cheongju 28159, Republic of Korea
1 shared publication - Eonjoo Park
Division of Infectious Disease Response, Capital Regional Center for Disease Control and Prevention, Seoul, Republic of Korea
1 shared publication - Eun Young Lee
Disease Management Division, Deogyang-gu Public Health Center, Goyang, Korea
1 shared publication - Eunkyoung Kim
Division of Infectious Disease Control, Bureau of Infectious Disease Policy, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 6 October 2023
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 18 (3) , 531-538
A Silent Outbreak of Hepatitis E Virus (HEV) Infection or False-Positive Reaction of Anti-HEV IgM after COVID-19 Vaccination? Epidemiological Investigation of an Outbreak in a Korean Factory Complex in 2022
Jeonghyeon Oh, Gwang Hyeon Choi, Yeonhwa Chang, Jina Kim, Kunhee Park, Hansol Yeom, Soonryu Seo, Jin Gwack, Sook-Hyang Jeong. Gut and Liver 2024;18:531-8. https://doi.org/10.5009/gnl230098
- 6 October 2023
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 18 (3) , 531-538
Open AccessA Silent Outbreak of Hepatitis E Virus (HEV) Infection or False-Positive Reaction of Anti-HEV IgM after COVID-19 Vaccination? Epidemiological Investigation of an Outbreak in a Korean Factory Complex in 2022
Jeonghyeon Oh, Gwang Hyeon Choi, Yeonhwa Chang, Jina Kim, Kunhee Park, Hansol Yeom, Soonryu Seo, Jin Gwack, Sook-Hyang Jeong. Gut and Liver 2024;18:531-8. https://doi.org/10.5009/gnl230098
- Open Access
- 23 March 2023
- Published by Korean Society of Epidemiology in Epidemiology and Health
- Vol. 45, e2023040
Detecting mpox infection in the early epidemic: an epidemiologic investigation of the third and fourth cases in Korea
OBJECTIVES: As few mpox cases have been reported in Korea, we aimed to identify the characteristics of mpox infection by describing our epidemiologic investigation of a woman patient (index patient, the third case in Korea) and a physician who was infected by a needlestick injury (the fourth case).METHODS: We conducted contact tracing and exposure risk evaluation through interviews with these 2 patients and their physicians and contacts, as well as field investigations at each facility visited by the patients during their symptomatic periods. We then classified contacts into 3 levels according to their exposure risk and managed them to minimize further transmission by recommending quarantine and vaccination for post-exposure prophylaxis and monitoring their symptoms.RESULTS: The index patient had sexual contact with a man foreigner during a trip to Dubai, which was considered the probable route of transmission. In total, 27 healthcare-associated contacts across 7 healthcare facilities and 9 community contacts were identified. These contacts were classified into high (7 contacts), medium (9 contacts), and low (20 contacts) exposure risk groups. One high-risk contact was identified as a secondary patient: a physician who was injured while collecting specimens from the index patient.CONCLUSIONS: The index patient visited several medical facilities due to progressive symptoms prior to isolation. Although the 2022 mpox epidemic mainly affected young men, especially men who have sex with men, physicians should also consider mpox transmission in the general population for the timely detection of mpox-infected patients.
- 23 March 2023
- Published by Korean Society of Epidemiology in Epidemiology and Health
- Vol. 45, e2023040
Open AccessDetecting mpox infection in the early epidemic: an epidemiologic investigation of the third and fourth cases in Korea
OBJECTIVES: As few mpox cases have been reported in Korea, we aimed to identify the characteristics of mpox infection by describing our epidemiologic investigation of a woman patient (index patient, the third case in Korea) and a physician who was infected by a needlestick injury (the fourth case).METHODS: We conducted contact tracing and exposure risk evaluation through interviews with these 2 patients and their physicians and contacts, as well as field investigations at each facility visited by the patients during their symptomatic periods. We then classified contacts into 3 levels according to their exposure risk and managed them to minimize further transmission by recommending quarantine and vaccination for post-exposure prophylaxis and monitoring their symptoms.RESULTS: The index patient had sexual contact with a man foreigner during a trip to Dubai, which was considered the probable route of transmission. In total, 27 healthcare-associated contacts across 7 healthcare facilities and 9 community contacts were identified. These contacts were classified into high (7 contacts), medium (9 contacts), and low (20 contacts) exposure risk groups. One high-risk contact was identified as a secondary patient: a physician who was injured while collecting specimens from the index patient.CONCLUSIONS: The index patient visited several medical facilities due to progressive symptoms prior to isolation. Although the 2022 mpox epidemic mainly affected young men, especially men who have sex with men, physicians should also consider mpox transmission in the general population for the timely detection of mpox-infected patients.
- Open Access
- 28 February 2023
- Published by Korea Disease Control and Prevention Agency in Osong Public Health and Research Perspectives
- Vol. 14 (1) , 15-22
The first reported hepatitis E outbreak in a food manufacturing factory: Korea, 2022
Objectives: On February 16, 2022, 12 cases of hepatitis E virus (HEV) infection were reported in a food manufacturing factory in Korea. The aim of this study was to identify additional cases and to determine the source of this HEV outbreak.Methods: This study was an in-depth investigation of 12 HEV immunoglobulin M (IgM)-positive cases and their demographic, clinical, and epidemiological characteristics. On-site specimens were collected from the environment and from humans, and a follow-up investigation was conducted 2 to 3 months after the outbreak.Results: Among 80 production workers in the factory, 12 (15.0%) had acute HEV infection, all of whom were asymptomatic. The follow-up investigation showed that 3 cases were HEV IgM-positive, while 6 were HEV IgG-positive. HEV genes were not detected in the HEV IgM-positive specimens. HEV genes were not detected in the food products or environmental specimens collected on-site. HEV was presumed to be the causative pathogen. However, it could not be confirmed that the source of infection was common consumption inside the factory.Conclusion: This was the first domestic case of an HEV infection outbreak in a food manufacturing factory in Korea. Our results provide information for the future control of outbreaks and for the preparation of measures to prevent domestic outbreaks of HEV infection.
- 28 February 2023
- Published by Korea Disease Control and Prevention Agency in Osong Public Health and Research Perspectives
- Vol. 14 (1) , 15-22
Open AccessThe first reported hepatitis E outbreak in a food manufacturing factory: Korea, 2022
Objectives: On February 16, 2022, 12 cases of hepatitis E virus (HEV) infection were reported in a food manufacturing factory in Korea. The aim of this study was to identify additional cases and to determine the source of this HEV outbreak.Methods: This study was an in-depth investigation of 12 HEV immunoglobulin M (IgM)-positive cases and their demographic, clinical, and epidemiological characteristics. On-site specimens were collected from the environment and from humans, and a follow-up investigation was conducted 2 to 3 months after the outbreak.Results: Among 80 production workers in the factory, 12 (15.0%) had acute HEV infection, all of whom were asymptomatic. The follow-up investigation showed that 3 cases were HEV IgM-positive, while 6 were HEV IgG-positive. HEV genes were not detected in the HEV IgM-positive specimens. HEV genes were not detected in the food products or environmental specimens collected on-site. HEV was presumed to be the causative pathogen. However, it could not be confirmed that the source of infection was common consumption inside the factory.Conclusion: This was the first domestic case of an HEV infection outbreak in a food manufacturing factory in Korea. Our results provide information for the future control of outbreaks and for the preparation of measures to prevent domestic outbreaks of HEV infection.